Preudhomme, Claude
Inserm
6 papers on CoChatORCID 0000-0002-1267-9546
Most cited papers
- Verified
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Ng, S. W. K., Mitchell, A., Kennedy, J. A., Chen, W. C., McLeod, J., Ibrahimova, N., Arruda, A., Popescu, A., Gupta, V., Schimmer, A. D., et al. (2016) · Nature
Acute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation
Cited by 912
- Verified
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21
Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 263
- Verified
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
Bally, C., Adès, L., Renneville, A., Sebert, M., Eclache, V., Preudhomme, C., Mozziconacci, M.-J., de The, H., Lehmann-Che, J., & Fenaux, P. (2014) · Leukemia Research
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 162
- Verified
Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma
Preudhomme, C., Roumier, C., Hildebrand, M. P., Dallery-Prudhomme, E., Lantoine, D., Laï, J. L., Daudignon, A., Adenis, C., Bauters, F., Fenaux, P., et al. (2000) · Oncogene
Lymphoma Diagnosis and TreatmentGenomics and Chromatin Dynamics
Cited by 135
- Verified
Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?
Lamandin, C., Sagot, C., Roumier, C., Lepelley, P., De Botton, S., Cosson, A., Fenaux, P., & Preudhomme, C. (2002) · Blood
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 38
- Verified · note
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML:GFM's “pick a winner” trial, with the impact of somatic mutations
Adès, L., Duployez, N., Guerci‐Bresler, A., Laribi, K., Peterlin, P., Vey, N., Thepot, S., Wickenhauser, S., Zerazhi, H., Stamatoullas, A., et al. (2022) · British Journal of Haematology
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free